• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肺肿瘤血栓性微血管病：当前诊断辅助手段与治疗方法的探索

Pulmonary tumor thrombotic microangiopathy: Exploration into current diagnostic aids and therapeutics.

作者信息

Ramakrishnan Pavithra, Dahiya Garima, Lindstrom Meghan, Thenappan Thenappan

机构信息

Department of Medicine University of Minnesota Minneapolis Minnesota USA.

Cardiovascular Division, Department of Medicine University of Minnesota Minneapolis Minnesota USA.

出版信息

Pulm Circ. 2023 Aug 15;13(3):e12278. doi: 10.1002/pul2.12278. eCollection 2023 Jul.

DOI:10.1002/pul2.12278
PMID:37593090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10427771/
Abstract

Pulmonary tumor thrombotic microangiopathy (PTTM) is an under-recognized cause of pulmonary hypertension and fulminant right ventricle failure. It is associated with a high mortality due to delay in diagnosis. We present two cases of PTTM, both diagnosed postmortem, highlighting the importance of timely identification and initiation of treatment for this near-fatal condition.

摘要

肺肿瘤血栓性微血管病（PTTM）是一种未得到充分认识的导致肺动脉高压和暴发性右心室衰竭的病因。由于诊断延迟，其死亡率很高。我们报告两例PTTM病例，均为死后诊断，强调了及时识别并启动针对这种近乎致命疾病的治疗的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b4/10427771/2149e767ebf0/PUL2-13-e12278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b4/10427771/038dfca70f39/PUL2-13-e12278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b4/10427771/2149e767ebf0/PUL2-13-e12278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b4/10427771/038dfca70f39/PUL2-13-e12278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6b4/10427771/2149e767ebf0/PUL2-13-e12278-g001.jpg

相似文献

1
Pulmonary tumor thrombotic microangiopathy: Exploration into current diagnostic aids and therapeutics.肺肿瘤血栓性微血管病：当前诊断辅助手段与治疗方法的探索
Pulm Circ. 2023 Aug 15;13(3):e12278. doi: 10.1002/pul2.12278. eCollection 2023 Jul.
2
Fatal pulmonary tumour thrombotic microangiopathy in patient with ovarian adenocarcinoma: review and a case report.卵巢腺癌患者致命性肺肿瘤血栓性微血管病：复习与病例报告。
BMC Cardiovasc Disord. 2022 Jan 5;22(1):1. doi: 10.1186/s12872-021-02434-3.
3
Pulmonary tumor thrombotic microangiopathy induced by ureteral carcinoma: a necropsy case report.输尿管癌所致肺肿瘤血栓性微血管病：一例尸检病例报告
Case Rep Oncol. 2014 Aug 27;7(2):605-10. doi: 10.1159/000366474. eCollection 2014 May.
4
Anlotinib dramatically improved pulmonary hypertension and hypoxia caused by Pulmonary Tumor Thrombotic Microangiopathy (PTTM) associated with gastric carcinoma: a case report.安罗替尼显著改善了由胃癌相关的肺肿瘤血栓性微血管病（PTTM）引起的肺动脉高压和低氧血症：一例报告。
Thromb J. 2023 Mar 27;21(1):33. doi: 10.1186/s12959-023-00477-4.
5
Dramatic Improvement of Pulmonary Tumor Thrombotic Microangiopathy in a Breast Cancer Patient Treated With Bevacizumab.贝伐单抗治疗的乳腺癌患者肺肿瘤血栓性微血管病显著改善
World J Oncol. 2023 Dec;14(6):575-579. doi: 10.14740/wjon1691. Epub 2023 Oct 21.
6
Pulmonary Tumor Embolism and Pulmonary Tumor Thrombotic Microangiopathy Causing Rapidly Progressive Respiratory Failure: A Case Series.肺肿瘤栓塞和肺肿瘤血栓性微血管病导致快速进展性呼吸衰竭：病例系列。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221086453. doi: 10.1177/23247096221086453.
7
Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer.伊马替尼可能是转移性乳腺癌中由肺肿瘤血栓性微血管病引起的肺动脉高压的一种新策略。
Springerplus. 2016 Sep 15;5(1):1582. doi: 10.1186/s40064-016-3280-4. eCollection 2016.
8
Pulmonary Tumor Thrombotic Microangiopathy as a Cause of Pulmonary Hypertension.肺肿瘤血栓性微血管病作为肺动脉高压的一个病因
JACC Case Rep. 2021 Jul 7;3(7):1029-1031. doi: 10.1016/j.jaccas.2021.04.013.
9
Pulmonary Tumor Thrombotic Microangiopathy: Case Report and Literature Review.肺肿瘤血栓性微血管病：病例报告及文献综述
J Acute Med. 2018 Sep 1;8(3):127-131. doi: 10.6705/j.jacme.201809_8(3).0006.
10
Insights on pulmonary tumor thrombotic microangiopathy: a seven-patient case series.肺肿瘤血栓性微血管病的见解：七例患者病例系列
Pulm Circ. 2017 Oct-Dec;7(4):813-820. doi: 10.1177/2045893217728072. Epub 2017 Aug 25.

引用本文的文献

1
Pulmonary tumor thrombotic microangiopathy: A case report and literature review.肺肿瘤血栓性微血管病：一例报告及文献复习
Medicine (Baltimore). 2025 Jul 25;104(30):e43284. doi: 10.1097/MD.0000000000043284.
2
A case of rapidly progressive fatal pulmonary hypertension in a patient with metastatic bladder cancer: reflections on the early recognition of pulmonary tumour thrombotic microangiopathy.一例转移性膀胱癌患者发生快速进展性致命性肺动脉高压：对肺肿瘤血栓性微血管病早期识别的思考
J Geriatr Cardiol. 2025 May 28;22(6):596-599. doi: 10.26599/1671-5411.2025.06.004.
3
Pulmonary Tumor Thrombotic Microangiopathy: A Rapidly Progressive Form of Pulmonary Hypertension in Cancer Patients.

本文引用的文献

1
Pulmonary tumor thrombotic microangiopathy: a systematic review.肺肿瘤血栓性微血管病：一项系统评价
Pulm Circ. 2019 Apr-Jun;9(2):2045894019851000. doi: 10.1177/2045894019851000.
2
Pulmonary tumour thrombotic microangiopathy.肺肿瘤血栓性微血管病
Curr Opin Pulm Med. 2016 Sep;22(5):421-8. doi: 10.1097/MCP.0000000000000297.
3
Pulmonary veno-occlusive disease.肺静脉闭塞病。
肺肿瘤血栓性微血管病：癌症患者中一种快速进展型肺动脉高压
JACC Case Rep. 2025 Mar 5;30(5):103194. doi: 10.1016/j.jaccas.2024.103194. Epub 2025 Feb 14.
4
A Rapid Review of Adenocarcinoma and Pulmonary Tumor Thrombotic Microangiopathy: A Deadly Duo.腺癌与肺肿瘤性血栓微血管病的快速综述：致命组合
Cureus. 2025 Jan 3;17(1):e76842. doi: 10.7759/cureus.76842. eCollection 2025 Jan.
5
Pulmonary tumor thrombotic microangiopathy due to early gastric carcinoma in a patient with no antemortem findings suggestive of primary malignancy.一名生前无原发性恶性肿瘤迹象的患者因早期胃癌导致肺肿瘤血栓性微血管病。
Pulm Circ. 2024 Mar 28;14(1):e12359. doi: 10.1002/pul2.12359. eCollection 2024 Jan.
Eur Respir J. 2016 May;47(5):1518-34. doi: 10.1183/13993003.00026-2016. Epub 2016 Mar 23.
4
Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy.血小板衍生生长因子受体酪氨酸激酶抑制剂伊马替尼对治疗由肺肿瘤血栓性微血管病引起的肺动脉高压有效。
Int Heart J. 2015;56(2):245-8. doi: 10.1536/ihj.14-220. Epub 2015 Feb 23.
5
Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy.肺肿瘤血栓性微血管病的生前成功诊断与治疗。
Intern Med. 2014;53(22):2595-9. doi: 10.2169/internalmedicine.53.2379. Epub 2014 Nov 15.
6
A case of pulmonary tumor thrombotic microangiopathy diagnosed by transbronchial lung biopsy and treated with chemotherapy and long-term oxygen and anticoagulation therapies.1例经支气管肺活检诊断为肺肿瘤血栓性微血管病并接受化疗、长期吸氧及抗凝治疗的病例。
Case Rep Pulmonol. 2013;2013:259080. doi: 10.1155/2013/259080. Epub 2013 Aug 29.
7
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.甲磺酸伊马替尼作为肺动脉高压的附加治疗：随机 IMPRES 研究的结果。
Circulation. 2013 Mar 12;127(10):1128-38. doi: 10.1161/CIRCULATIONAHA.112.000765. Epub 2013 Feb 12.
8
Pulmonary tumor thrombotic microangiopathy caused by gastric cancer.由胃癌引起的肺肿瘤血栓性微血管病。
Ann Thorac Med. 2012 Jul;7(3):168-9. doi: 10.4103/1817-1737.98853.
9
Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension.伴有肺动脉高压的肺肿瘤血栓性微血管病
Cancer. 1990 Aug 1;66(3):587-92. doi: 10.1002/1097-0142(19900801)66:3<587::aid-cncr2820660330>3.0.co;2-j.